Current status: 820 hESC lines, 2982 hiPSC lines, and 94 clinical studies, and 370 certificates

Monthly statistic from Jan 1, 2022

Posted on January 1, 2022

total lines3802
hESC lines820
hiPSC lines2982
derivation countries40
projects 211
providers677
clinical studies 94
subclones1407
certificates370
cell line certificates266
project certificates104